Skip to main content

Guidelines

What's new

COVID-19 has revealed new and exciting ways we can confront the pandemic of diabetes. A new peer-reviewed paper sponsored by diaTribe outlines some of the lessons learned and how we can approach health and wellness in the future. Continue Reading »

The American Diabetes Association released its 2022 Standards of Care, which provides an annual update on practice guidelines. Here's what these new updates mean, including your options for first-line glucose-lowering therapies, when you should be screened for diabetes, the expanded use of diabetes care technology, and more. Continue Reading »

Rice is a main food staple in many cultures, but it can cause glucose spikes for people with diabetes. From rice alternatives to smaller portions, here are some ways to navigate this challenge. Continue Reading »

A recent consensus report from leading experts details a new definition for what it means to have type 2 diabetes in remission and why it is important to use the proper terminology in place of other words, such as “reversal” or “cure.” Continue Reading »

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the largest conference in diabetes, including automated insulin delivery, continuous glucose monitoring, extremely promising drugs in development, and more. Continue Reading »

The US Preventive Services Task Force (USPSTF) has updated its recommendations, encouraging prediabetes and type 2 diabetes screening for people with excess weight or obesity starting at age 35. It also encourages the use of preventive lifestyle interventions when possible. Continue Reading »

Have you gotten your COVID vaccine yet? New CDC guidelines recommend that people with type 1 and type 2 diabetes, and obesity, be given priority to receive COVID vaccines. Continue Reading »

The American Diabetes Association recommends SGLT-2 inhibitors or GLP-1 agonists for people with heart and kidney problems, the use of Time in Range in diabetes management, and continuous glucose monitors for all people with diabetes on multiple daily injections or pump therapy. It also encourages healthcare professionals to consider social determinants of health, refer people to diabetes self-management education services, and reduce barriers to care.  Continue Reading »

Pages